Bio Developments

New Melanoma Vaccine Tech Enters Ph I Trial

Harvard’s New Melanoma Vaccine Tech Enters Ph I Trial

By Zachary Brennan

A newly developed implantable melanoma vaccine is now in Phase I clinical trials thanks to the efforts of a cross-disciplinary team of engineers, scientists and clinicians from Harvard University and the Dana-Farber Cancer Institute.

CST Unveils HER3 Rabbit mAb for Researchers

CST Unveils HER3 Rabbit mAb for Researchers

By Zachary Brennan

Cell Signaling Technology launched a new HER3 rabbit monoclonal antibody (mAb) for researchers studying HER2-mediated breast, lung and ovarian tumors. 

GSK Launches $50M ‘Electroceuticals’ Venture Capital Fund

GSK Launches $50M ‘Electroceuticals’ Venture Capital Fund

By Zachary Brennan

GlaxoSmithKline is gambling $50M on a venture capital fund that will invest in 20 projects that pioneer bioelectric drugs and technologies that aim to target individual nerve fibres or specific brain circuits to treat an array of conditions.

To QbD or not to QbD? That is the Question...

To QbD or not to QbD? That is the Question...

By Dan Stanton

Europe may soon approve the first biologic made according to quality by design (QbD) principles, but opinions are still split over whether the approach should even be applied to biopharmaceuticals.

Heston was livid

Editor's blog

Lies of The Planet of The Apes?

By Gareth Macdonald

Could a genetically engineered adenovirus really spark a simian revolution and make chimps our masters? BioPharma-Reporter.com looks at the ‘science’ of the 2011 movie “Rise of the Planet of the Apes.” 

Pfizer Preps for Pipeline with $130m Irish Investment

Correction

Pfizer Preps for Pipeline with $130m Irish Investment

By Dan Stanton

After patent expiration led to facility shuttering and cutbacks, Irish manufacturing will receive a $130m (€100m) boost to prepare for Pfizer’s new pipeline, the company says.

China, Taiwan Begin Shift to Regulatory Convergence

Dispatches from DIA

China, Taiwan Begin Shift to Regulatory Convergence

By Zachary Brennan

In a momentous first for both countries, regulatory officials from China and Taiwan sat down at the same table on Tuesday and discussed their relatively similar ideas around the regulation of drug approvals.

Pharma People: New Board Member at BMS

Pharma People: New Board Member at BMS

By Dan Stanton

BMS have appointed a new director and ex Shire-CEO joins Questcor - yes, you've guessed it, it's in-Pharmatechnologist.com's weekly pharma people round-up.

Catalent Begins $35m Controlled Release Expansion

Catalent Begins $35m Controlled Release Expansion

By Dan Stanton

Catalent says customers are applying controlled release technology to transform drugs into better treatments across all stages of development as it expands its Kentucky manufacturing site.

Follow us

Webinars